News

CURE1d
U.S. Centers Seek Namodenoson for Pancreatic Cancer Compassionate Use
U.S. medical centers are seeking FDA authorization for the compassionate use — or expanded access — of Namodenoson for ...
Seeking Alpha8d
Theriva Biologics Announces Presentation of Data from the Phase 1b/2a Clinical Trial of SYN-004 (ribaxamase) in Allogeneic Hematopoietic Cell Transplant Recipients
The ongoing randomized, double-blinded, placebo-controlled Phase 1b/2a clinical trial is being ... A previously completed placebo-controlled Phase 2b clinical trial of 412 patients demonstrated ...
Business Insider5d
NeOnc Technologies expects full enrollment in Phase 2a trial of NEO100-01
NeOnc Technologies (NTHI) announced that it expects full enrollment in its Phase 2a clinical trial for its lead therapeutic candidate, NEO100-01 in September. Only six patients remain to complete ...
The Victoria Advocate11d
Alphyn Announces First Patient Dosed in CLEAR-AD1 Global Phase 2b Clinical Trial Program of Zabalafin Hydrogel for Atopic Dermatitis
"The initiation of patient dosing in our CLEAR-AD1 Phase 2b clinical trial is another ... Alphyn completed two AD Phase 2a clinical trials that met all primary and secondary endpoints ...
American Association of Individual Investors2d
Why Arrowhead Pharmaceuticals, Inc.’s (ARWR) Stock Is Down 10.49%
Arrowhead Pharmaceuticals, Inc.’s ARWR share price has dipped by 10.49%, which has investors questioning if this is right ...
Pharmabiz6d
Theriva Biologics presents data from phase 1b/2a trial of ribaxamase in allogeneic hematopoietic cell transplant recipients
Rockville, Maryland Saturday, April 12, 2025, 18:00 Hrs [IST] ...